Cybin D/B/A Helus Pharma (HELP)
Develops psilocybin-based drugs to treat depression and anxiety disorders.
$7.60-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.5%
The outlook
HELP is trading at $7.60 with unanimous Strong Buy analyst consensus from nine analysts. The stock sits well above its short- and long-term moving averages and is positioned in the upper half of its 52-week range. The average analyst price target sits roughly 362% above the current price.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 9 analysts
Price trendAbove its 50- & 200-day averages
52-week range72% of the way from its 52-week low to high
Price targetAvg target +362% vs current price
Analyst price target
~12-month · 9 analysts$35.13average target+362.2% vs now
Now $7.60
Low $7.97High $69.77
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$471.1M
52-wk high
$9.12
52-wk low
$3.76
50-day avg
$5.50
200-day avg
$6.05
Trailing P/E
—